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LABORATORY EFFICACY STUDY WITH A WARFARIN BAIT TO CONTROL THE
BLACK-TAILED PRAIRIE DOG
JEFF J. MACH, Genesis Laboratories, Inc., P.O. Box 270696, Fort Collins, Colorado 80527-0696.
ABSTRACT: Control of the black-tailed prairie dog {Cynomys ludovicianus) is important for the reclamation of pasture
ground for domestic cattle and limiting the spread of disease to humans and other wildlife. Six different concentrations
of warfarin bait were fed to prairie dogs to determine mortality. Without the access to dietary vitamin K, the prairie
dogs were susceptible to the warfarin bait. However, some of the prairie dogs recovered and survived the test after bait
exposure was terminated. This could be due to physiological differences and the availability of fat-soluble vitamin K.
The six different concentrations of warfarin consumed by the prairie dogs were correlated to the increase in treatment
group (r=0.916). Body weight loss generally increased as the treatment group dosage increased. The control group
was the only group which increased in body weight. The whole body tissue analysis of the prairie dogs from treatment
groups 44.8, 233.0, and 777.6 ppm was correlated to the increase in treatment group (r=0.709).
KEY WORDS: Cynomys ludovicianus, black-tailed prairie dog, toxicant, rodenticide, warfarin, bioassay
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INTRODUCTION
Black-tailed prairie dog {Cynomys ludovicianus)
numbers in the Great Plains were estimated at 5 billion in
the early 1900s (Merriam 1902). At that period of
history, they were considered to be a pest to the ranchers
and farmers because of their feeding on crops and grass
planted by the early settlers. Grazing biomass has been
decreased by the feeding action of prairie dogs (Taylor
and Loftfield 1924; Hansen and Gold 1977; O'Meilia et
al. 1982; Knowles 1986). Prairie dogs are also a
reservoir of disease that affect humans and other wildlife
(Barnes 1982). For these reasons, the prairie dog is still
being eradicated with the use of toxicants and firearms
resulting in lower densities and widely scattered colonies
(Clark et al. 1982; Foster and Hygnstrom 1990).
Even with the current small population of prairie
dogs, the farmers and ranchers continue to use control
techniques. The author is proposing warfarin as a
possible answer because it is a cost effective rodenticide,
it is relatively nontoxic to birds (Christopher et al. 1984;
Hagan and Radomski 1953), it quickly degrades in the
gastro-intestinal tract (half-life of 42 hours) (Ford 1993),
it is rapidly excreted from the body (Wong and
Solomonraj 1980), animals often do not develop "bait
shyness" (Meister 1996), and it is relatively safe with
respect to secondary poisonings (Aulerich et al. 1987).
The purpose of this study was to develop a
concentration of warfarin bait from five formulations
(0.005%, 0.01%, 0.025%, 0.05%, and 0.1%) that would
be effective in the management of black-tailed prairie
dogs.
OBJECTIVES
The objective of this bioassay test was to determine
the efficacy of five concentrations of warfarin for
managing black-tailed prairie dogs. Warfarin
consumption was monitored to determine possible
secondary hazard. Physical, behavioral, and anatomical
observations were made to assess anticoagulant poisoning.
Whole body tissue analysis was performed to calculate the
warfarin accumulation at the time of death. Also, bait
analysis will help determine if the mixing technique is
sufficient to produce a homogeneous mixture.
In a companion study, the author tested the secondary
hazard potential of warfarin-poisoned prairie dogs on
domestic ferrets {Mustela putorius fiiro).
METHODS
Warfarin Formulations
Five concentrations of warfarin bait were tested
(0.005%, 0.01%, 0.025%, 0.05%, and 0.1%). The
warfarin technical product (99% purity) was supplied by
Sigma Chemical. Three warfarin concentrates were made
(0.5%, 1.0%, and 2.0% warfarin) for the five different
warfarin formulations to aid in obtaining a sufficient
homogeneity. Five warfarin formulations were prepared:
0.005%, 0.01%, 0.025%, 0.05%, and 0.1%. The
control bait, which contained 0% warfarin, was mixed in
the same manner as the other formulations. The exact
formulation was kept in the raw data for confidentiality.
After each ingredient was added, the mixer was
operated for 20 seconds to mix the ingredients together.
When large amounts of the concentrate were to be added
(500 and 1,000 ppm groups), small portions of the
concentrate were added and then mixed for about 20
seconds. After all of the ingredients were added, the
mixer was run for 15 minutes to achieve a homogenous
mixture. Samples were collected from each formulation
for freezer storage stability, animal room stability, and
homogeneity. All of the formulated bait, including
samples, were frozen in plastic bags. The bait was
analyzed for freezer storage stability, animal room
stability, and homogeneity.
Test System
All methods used in the study were approved by the
Genesis Laboratories, Inc. Institutional Animal Care and
Use Committee (Project #96018). Black-tailed prairie
dogs were live trapped from a colony in Larimer County,
Colorado. Traps were set near the burrow openings and
worked into the ground to cover the metal bottom with
soil. Clean rolled barley was placed on the trigger device
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as well as a path leading out of the trap for a distance of
about 0.5 meters. Traps were checked at least twice
daily.
The prairie dogs were transported to Genesis
Laboratories, Inc. in the back of a covered truck in the
same trap in which they were captured. All animals were
dusted with flea powder containing pyrethrin to control
ectoparasites.
The prairie dogs were placed into a cloth bag and
plastic container, they were then weighed on a top loading
Ohaus dial-o-gram balance. The scale had been calibrated
and tared for the cloth bag and the plastic container.
Maturity was assessed according to body weight (675
grams and 775 grams for females and males, respectively)
(Hoogland 1995). Preliminary body weight was measured
on the first day of the acclimation period when the prairie
dogs were assigned to treatment groups. A final
assessment of maturity by body weight was taken on Day
0 and were replaced with extra animals if they were
underweight. Body weights were taken at test termination
or death to assess weight loss or gain.
Prairie dogs were observed visually during the
acclimation period. They were randomly assigned to
cages from group housing one day before the acclimation
period. The individual cages had metal screen bottoms
with a surface area of at least 4,650 cm2 and a minimum
height of 46 cm (National Research Council 1992).
Prairie dogs received a basal diet of laboratory pellets
(Manna Pro Lab Cubes from St. Louis, MO), rolled
barley, and water ad libitum. The bedding and water
bottles were changed and cleaned weekly, and the water
and feed levels checked daily. Cages and racks were not
cleaned during the study because handling of the animals
could cause lesions, bruises, or injury which could bias
mortality estimates (Penumarthy and Oehme 1978).
The minimum/maximum temperature and humidity of
the animal room was recorded daily during the entire
holding period with a calibrated digital
hygrometer/thermometer. The temperature and humidity
in the study room was maintained at approximately 16 to
26CC and 55 ± 25%, respectively. Ventilation was
checked often.
The animals were acclimated to test conditions for 10
days prior to the warfarin bait administration. Five
females and three males were placed into acclimation with
the initial group after the initial start date. One male was
captured one day late, and two males and five females
were captured two days late. These extra animals were
used in the event some of the other animals did not reach
the mandatory weight limits for each sex set by the study
protocol.
Animals were randomly assigned to treatment groups,
using the computer program "Ran30" (Faisal, Colorado
State University, Fort Collins, CO), a program designed
to choose random numbers according to the number that
is required.
The feeding-test period was conducted for 15 days,
during which all formulations were presented until the end
of the test period or death. Seventy grams of each diet
was presented daily in stainless steel feed cups. The feed
cups were attached to a 30 cm X 30 cm sheet of particle
board to catch spilled feed and stabilize the feed cup. A
flat circular fowler with 10 mm holes, used for rodents,
was placed over the bait to limit spillage. Bait
consumption was measured and cups were refilled with
fresh bait daily. After the exposure period, prairie dogs
were fed the basal laboratory diet and observed for 10
days for signs of warfarin toxicity.
The prairie dogs were observed daily during their
entire holding period. Any physical or behavioral signs
that could help lead to the identification of sickness or
anticoagulant poisoning during the test were recorded.
The prairie dogs were observed once each day during the
10-day acclimation period. The prairie dogs were
observed twice daily during the feeding-test period and
post-test observation periods of the experiment. The
Environmental Protection Agency (EPA) recommended
the 15 day feeding and a 5 day post-test observation. A
10 day post-test was used to be certain of mortality.
Necropsies were conducted on all animals that died during
the test. An incision was made through the skin from the
anus to the lower jaw. All major organs were observed
for hemorrhaging and signs of anticoagulant poisoning in
the abdominal and thoracic regions. A few cranial
regions were incised to inspect for hemorrhaging.
After the prairie dogs were found dead during the
test, the carcasses were labeled, wrapped in foil, and
stored in a freezer for later analysis. Nine prairie dogs,
three from each of the 50, 250, and 1,000 ppm treatment
groups, were randomly chosen from the freezer to be
analyzed for whole body residues of warfarin. This gave
a representative range of the treatment groups. A
laboratory-validated method was used. Also, all baits
were analyzed for warfarin levels. A laboratory-validated
method was used.
Statistics were performed after the completion of the
test by SPSS for Windows, release 7.5. Various tests
were performed based upon the capabilities and
limitations of the available data. Linear regression was
used to compare dependent and independent variables in
relation to each other. Levene's test for homogeneity of
variances was used to compare the variances within
treatment groups. If the variances were significantly
different, a Kruskall-Wallis non-parametric test was used
to identify differences between variances. If the results
of the Levene test showed the variances within the
treatment groups were not significantly different, an
analysis of variance (ANOVA), a parametric test,
comparing treatment group means, was used to identify
differences between the means of the variances.
Following analyses of variances, the Tukey's honestly
significant difference test (HSD) was performed. This
test identifies significant differences of the means of the
treatment groups. The test shows which treatment groups
are similar and which are different from the others.
Significance values classify the significant difference
between the treatment groups which are most distant from
each other.
The computer program "Probit" (Charles
Breidenstein, former section chief of statistics, Denver
Wildlife Research Center) was used to calculate the LC50
and LCJO values.
RESULTS
The warfarin baits used in this study were formulated
to be a nominal concentration of 50, 100, 250, 500, and
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1,000 ppm. The validated analytical extraction procedure
resulted in warfarin baits of actual concentrations of 44.8,
89.5, 233.0, 407.0, and 777.6 ppm. For the remainder
of the report, the actual concentrations will be used for all
calculations and presented results.
The daily observations taken during the exposure
period included symptoms of diarrhea, ataxia, immobility,
hemorrhage, hyperreactive, hyporeactive, bloody stool,
labored breathing, hind limb paralysis, moribund, and
found dead. During the first five days of the exposure
period, only one female prairie dog showed a sign
affiliated with warfarin intoxication—lethargy. On days
6 through 10, the prairie dogs began showing signs of
hemorrhaging (nose, mouth, anus) or lethargy, with
increasing severity as the study progressed. The first
death was on day 8 of the exposure period. On days 11
to 15, the severity of the symptoms continued to progress
with more individuals becoming moribund or found dead.
After the feeding test exposure, the animals were
placed in a 10-day post-test observation period. Some of
the animals continued to deteriorate physically, while
some of the animals began to show improvements in their
physical condition. In an extreme case, M23, in the
233.0 ppm treatment group, was classified as being
"moribund" (M) for 13 days, and then upgraded to
lethargic (HY) on day 8 of the post-test observation
period.
Variances among the treatment groups differed
significantly (P=0.128). An ANOVA showed a
difference between the treatment groups (P< 0.000).
Tukey's HSD test identified a difference between the
control group and the treated groups, and only a small
difference among the treated groups (Tukey's
HSD=0.430, P<0.05) (Figure 1).
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Treatment Group Dosage (ppm)
Figure 1. Total consumption of bait (grams) by prairie dogs fed
six different concentrations of warfarin bait. The prairie dogs
were fed for 15 consecutive days in a no-choice regime. Each
square represents the consumption of one prairie dog.
Warfarin consumption was highly correlated (r=0.916)
with the concentration of warfarin baits presented (Figure
2). A Levene test of homogeneity of variances showed
that there is a difference between the variances among the
treatment groups differed significantly (11.647, df!=5,
df2=54, P < 0.000). A Kruskall-Wallis test indicated that
the treatment means were different (P> 0.000).
Consumption of the two highest concentrations was
significantly greater (Tukey's HSD = 1.000, 10.00 at
P<0.05) than the three lower concentrations.
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Figure 2. Consumption of warfarin (mg/kg body weight) by
prairie dogs fed six different concentrations of warfarin. Prairie
dogs were fed warfarin bait in their respective treatment groups
for 15 days. Each square represents total consumption of
warfarin of one prairie dog.
After the exposure and post-test observation periods
were concluded, treatment group mortality was calculated
(Table 1). Interestingly, the 777.6 ppm group did not
produce 100% mortality like the 407.0 ppm treatment
group below it. One male and one female survived.
Further investigation revealed that the female prairie dog
had eaten only 186.1 mg of warfarin/kg body weight and
lost 267 grams of body weight. The male ate only 128.6
mg of warfarin/kg body weight and lost 146 grams of
body weight. The female and male ate 43.3 and 121.9
mg of warfarin/kg body weight less than the average of
each sex. The female lost 38 grams more than the female
mean, and the male lost 24 grams less than the male
mean.
According to the efficacy data presented, a computer
analysis from "Probit" gives an LC^ value of 97 mg/kg
body weight. The LC^ of the prairie dogs was calculated
at 831 mg/kg body weight. Other Probit analyses were
performed because of the 80% efficacy achieved in the
highest treatment group. One was performed without the
777.6 ppm group and another was performed with 100%
efficacy in the 777.6 ppm group. These alternate
analyses showed similar LC50 values of 94 and 93 mg/kg
body weight, respectively. However, the LCgo of both of
the alternate analyses was much lower, 441 and 376
mg/kg body weight, respectively.
The prairie dog weights in each treatment group were
recorded at the beginning of the exposure period. The
overall body weight of the prairie dogs was 897 grams.
Mean body weights of prairie dogs across treatment were
similar (F=0.657, P=0.658) as were the variances
(L=0.545, P=0.741).
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Table 1. Treatment group mortality and mean and range of warfarin consumption per treatment group.
Concentration (ppm)
Mean Warfarin Consumption mg a.i./kg Body Weight
Mortality (%) (Range)
Control (0)
44.8
89.5
233.0
407.0
777.6
10
10
10
10
10
10
0
30
50
60
100
80
0
13.73 ( 6.30- 21.52)
29.85 ( 16.27- 43.31)
55.31 ( 15.99-107.65)
161.42 ( 65.08-208.16)
239.94 (128.63-352.40)
The mean body weight of the animals decreased
in all groups except the control group^ Table 2
shows the body weight loss or gain according to
treatment group, male, and female. Variances among
the treatment group showed no significant difference
(L= 1.497, p=0.208). As a result, analysis of variance
indicated treatment means were different (P<0.000).
Weight loss from consumption of the treated baits
was significantly different from consumption of
the untreated control bait (Tukey's HSD = 1.000,
P<0.05).
The necropsies showed small to large amounts
of hemorrhaging, independent of the treatment dose.
During and after the exposure period, hemorrhaging was
observed in the nose, eye, mouth, stomach, liver,
intestines, cecum, kidneys, anus, heart, lungs, brain, and
subcutaneous and neck regions. The hemorrhaging was
so extensive in seven animals, the abdomen (5), thorax
(1), or subcutaneous (1) became pooled with blood.
Twenty-nine of 32 prairie dogs that died during the test
were observed to have extensive fat in the abdominal
subcutaneous or within the abdomen. Also, fat was
present in the thoracic region in 25 of 32 prairie dogs.
Six grams fat was observed from around the heart of one
prairie dog.
Using a validated laboratory method, whole body
analysis of the prairie dogs resulted in a range from 0.080
to 6.072 ppm in the 50, 250, and 1,000 ppm treatment
groups (Table 3).
The warfarin accumulation within the tissue is
correlated to the treatment group (r=0.709). The mean
days to death of the prairie dogs used for the tissue
analysis in the 44.8, 233.0, and 777.6 ppm treatment
groups is 11, 10, and 18.
Also, using a validated laboratory method,
concentration verification, laboratory stability, and freezer
storage stability of all treatment group warfarin baits were
calculated. The t-test showed there was no significant
difference between the same treatment levels with the
three different samples taken.
Table 2. Body weight1 loss or gain from the study initiation to termination or time of death. The control group is the
only group which gained weight. All other treatment groups showed a general increase in weight loss as the treatment
group dosage increased.
Treatment Group
Control
44.8
89.5
233.0
407.0
777.6
Mean Treatment Group
Loss/Gain (g)
31.2
-77.0
-80.7
-112.7
-94.7
-142.2
Mean Male Loss/Gain
(g)
51.4
-111.2
-110.8
-118.2
-128.2
-170.2
Mean Female Loss/Gain
(g)
11.0
-42.8
-50.6
-107.2
-61.2
-114.2
'Body weight calculations were taken from Day 0 of the feeding test and at study termination or at time of death.
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Table 3. Concentration of warfarin within the whole body tissue of the prairie dogs of treatment
groups 44.8, 233.0, and 777.6 ppm, respectively. Animals were chosen at random to be analyzed
from animals that had died during the test. The sample identification denotes the sex [male (M)
or female (F)], animal number, and sequence of sample used from extraction procedure.
Sample Identification Concentration (ppm)
M13A
F17A
F18A
M32A
M34C
F35A
M51A
M52A
F56A
0.091
0.631
0.080
1.495
1.528
0.509
1.139
6.072
2.131
DISCUSSION
The results show the physiological variation in the
reaction to the different treatments of warfarin baits.
Even with the increased amount of warfarin in the higher
levels of bait, the 777.6 ppm treatment group failed to
produce 100% mortality like the treatment group below it
(407.0 ppm). One prairie dog of each sex survived. The
male ate much less warfarin bait and lost less weight than
the average prairie dog within the same treatment group.
The female ate slightly less, but lost much more body
weight than the average female within the same treatment
group. It is believed that these two individuals survived
because of their physiological reactions to the warfarin,
possibly involving higher metabolism of the warfarin or
a greater ability to synthesize vitamin K from gut
bacteria—the antidote for warfarin poisoning (Hadler and
Buckle 1992). Mortality is expected to be variable.
Physiological difference within an animals species is
common. For example, LD^ tests predict the required
dosage to kill 50% of the population from a range of
responses of hypersusceptibility to levels of appeared
resistance to a certain chemical compound. Adjustments
in application rates are made for such a variability in
susceptibility.
The initial effects of the warfarin appear to be
independent of treatment group dosage. The final
response, mortality, is the factor which varies most. The
two extremes of warfarin consumption, 6.3 and 352.4 mg
warfarin/kg body weight, caused death in both cases.
Some of the lower treatment groups, even with continuous
no-choice feeding, failed to cause sufficient trauma to the
prairie dogs to result in death. This is why higher
treatment dosages must be used for ample control.
The metabolism of the prairie dogs appears to be
variable, requiring different amounts of feed to supply
themselves with enough nutrients. It is shown that there
is no statistical significant relationship between the size of
the prairie dog and the amount of bait eaten. The range
of the body weights of the prairie dogs was between 676
and 1226 g. It was expected that the larger prairie dogs
would eat more bait compared to the smaller animals,
but this was not the case. There was only a small
relationship between these two factors. Varying factors
which could be affecting the prairie dogs are stress
from laboratory holding and close physical environment
to humans. Also, these prairie dogs were captured in
late fall. They were probably storing nutrients for
the upcoming winter in the form of fat. The larger
animals could have had sufficient supplies of nutrients
while the other smaller prairie dogs had to continue
foraging to supply themselves with sufficient nutrient
stores.
Statistical tests show that the control group is
significantly different from the other treatment groups
because of the larger amount of bait eaten by the control
prairie dogs. This difference could be conceived as a
palatability problem because of the difference in
consumption from the control group, but most likely, this
is a negative response from the warfarin. Warfarin
poisoning signs appeared at a similar time (days 5 to 11)
with no dose response evident. In addition, the warfarin
was causing similar decreases in consumption throughout
the treatment groups, again, no dose response was
apparent. The warfarin is causing illness in all treated
groups at a similar time, resulting in a similar decreased
consumption.
Statistical analysis of the warfarin consumption
displayed a high correlation coefficient. This indicates
that as the treatment dosage increases the amount of mg
warfarin/kg body weight will increase. Since the
ingestion of warfarin did not decrease at the higher
treatment levels, no palatability problems existed.
Meehan (1984) reports higher warfarin treatments as
being unpalatable, but to correct this problem, a high
purity of warfarin was used and the taste was disguised
with feed additives.
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Prairie dogs used in the test were randomized into
treatment groups to achieve an unbiased design which the
statistical tests showed. Resulting body weights taken at
time of death or at test termination revealed significant
body weight loss throughout the exposure and post-test
observation period.
Nearing the end of the exposure period, the prairie
dogs were not eating much bait because of their
warfarin-induced sickness. For example, fat and muscle
are the only components which could be slowly lost. Fat
was a large component of many prairie dogs that were
necropsied at the end of the study. The necropsies
revealed small to large amounts of hemorrhaging
depending upon the individual. Fat was very common in
the abdominal and thoracic cavities as well as in other
areas. Fat, which is partly composed of vitamin K, could
have been used for the metabolism of the warfarin.
Vitamin K, a fat soluble vitamin could have been supplied
to the liver for the metabolism of warfarin and reversal of
the anticoagulant action.
In a similar Genesis Laboratories, Inc. study with
prairie dogs, a factor believed to be the cause of the lack
of efficacy was presence of alfalfa cubes. Two prairie
dogs died and only three observations of warfarin signs
were observed. According to the United States-Canadian
Tables of Feed Composition (1982), dry alfalfa can have
as high as 14.2 mg of fat-soluble vitamin K per kg.
According to Donoco and Haft (1976), and Seegars and
Walz (1986), vitamin K is needed by the liver to produce
prothrombin (factor II), a major component of the blood
clotting mechanism.
Other factors directly involved with vitamin K are the
factors VII (serum prothrombin conversion accelerator),
IX (plasma thromboplastin component), and X
(Stuart-Prower factor). In short, these factors, along with
factor II, are most important in beginning the clotting
system, which is often referred to as a clotting cascade.
This procedure has positive feedback which continues to
amplify the reaction intensity. When this cascade is
inhibited by warfarin, the result is a failure in blood
coagulation (Church and Pond 1988).
The calculated prairie dog LC50 places this species in
close proximity to the other rodents listed above. The
calculated LCgo (831 mg/kg) seems to be very high
because of the survivors in the 777.6 ppm treatment
group. If the 777.6 ppm treatment group had 100%
mortality, the calculated LCgo would have been 376 mg/kg
body weight, less than one-half of the actual. The
apparent large range of physiological differences of the
prairie dogs, therefore, require a higher dosage to achieve
high mortality.
With the removal of the alfalfa cubes in the present
study, high mortality was achieved in the higher treatment
groups demonstrating diet may be an important factor in
warfarin efficacy.
In several cases in study 96018, individuals in the
lower treatment groups showed a recovery from the
warfarin administration. In addition, between days 11 and
15, almost no bait was eaten, exposing the animals to only
10 days of feeding. Prairie dog M23 lost 185 grams
(21% of its initial body weight) over the 25 days of test
substance exposure and post-test observation period,
leaving the animal very thin. The vitamin K in the fat
could have provided enough nourishment throughout this
period (Church and Pond 1988). To illustrate, vitamin K
is fat soluble and is able to be stored within fat along with
vitamins A, D, and E (Church and Pond 1988; Machlin
1984). This allows consumption of vitamin deficient diets
over a longer period of time before deficiency signs
appear, compared to water soluble vitamins (C, B6, B12,
thiamin, and riboflavin).
This could be a reason for the marginal recovery of
M23 and the ability of many others to sustain themselves.
If vitamin K is stored within the fat reserves of the prairie
dogs, which are very extensive, the vitamin K could be
metabolized from the fat as an antidote to warfarin.
Vitamin K can also be replaced by gut bacteria
(Hadler and Buckle 1992). Bacterial synthesis of vitamin
K has also been documented to be absorbed in the lower
part of the intestinal tract where the bacterial population
is greatest (Machlin 1984). Specifically, vitamin K is
absorbed in the large intestine of mammals sufficiently
enough to prevent deficiency symptoms when presented
a vitamin K deficient diet (Hollander ****).
It would appear with vitamin K being acquired from
gut bacteria and the fat in this study, there would be a
sufficient supply of vitamin K to produce an antidote.
The resulting deaths increased as the concentration level
increased, but there was death caused by a large range of
warfarin consumption. The two extremes of warfarin
consumption, 6.3 and 352.4 mg warfarin/kg body weight,
caused death in both cases. The higher warfarin
consumption values could be individuals that are
metabolizing the warfarin more efficiently than the others.
If they were not, more mortality in all treatment groups
would be expected.
Certain application techniques can be used to help
increase the mortality of the prairie dogs. First, since fat
is known to store vitamin K, an antidote to the warfarin,
it would be beneficial to eliminate periods of baiting when
the prairie dogs are in the process of storing nutrients for
winter survival. Second, if bait can be applied when
dietary vitamin K is low, an increased mortality could be
expected. Using these ideas in conjunction, the
significance of vitamin K from the diet and fat reserves
must be considered to produce an effective antidote.
These ideas signify the pertinence of applying the bait
during a period of low vegetative biomass and quality,
and when the animals have a low fat content/body
weight—early spring.
The tissue analysis resulted in a high correlation
between warfarin consumption and tissue accumulation,
but the evident variation could be explained by differences
in bait consumption and physiology of the prairie dog.
The mean days to death of the animals in the tissue
analysis is so variable that again, the physiological
differences in the prairie dogs is displayed.
CONCLUSIONS
The highest mortality in this study was found to be
100% at the 407.0 ppm level. The highest concentration
of 776.7 ppm was not the most efficacious (80%),
showing the differences in prairie dog physiology. The
fat and dietary vitamin K have the ability to provide an
antidote to the warfarin bait which must be considered
into a baiting schedule specific to these parameters. At
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least a 407.0 ppm bait should be used to control less
susceptible prairie dogs.
Prairie dog tissue samples yielded residue levels
which increase as the treatment group dosage increases.
The technique used for mixing the bait repeatedly
produced homogeneous batches with all treatment levels.
All concentrations of the warfarin bait are stable in the
laboratory environment.
The control of the black-tailed prairie dog is an
important issue which influences many other animal
population. Where prairie dog control is necessary, a
warfarin bait could provide an alternative to other baiting
practices. The effects of warfarin are easily reversible
which is an important consideration in human and
non-target safety.
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